Aixa Toledo Garcia in Albany, New York

Medical School: Sorry, her university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Aixa Toledo Garcia is listed as: Rheumatology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 6507055001
NPI #: 1891956751
NPI Created On: 06/23/2008
NPI Last Updated Listed as: 04/22/2021
Primary Taxonomy Code: 174400000X
License Number:
249650
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

---

Services and Procedures include:

1. Aspiration and/or injection of large joint or joint capsule
2. Insertion of needle into vein for collection of blood sample
3. X-ray of chest, 2 views
4. X-ray of lower and sacral spine, minimum of 4 views
5. X-ray of shoulder, minimum of 2 views
6. X-ray of hand, minimum of 3 views
7. Bone density measurement using dedicated x-ray machine
8. Bone density measurement using dedicated x-ray machine
9. Complete blood cell count (red cells, white blood cell, platelets), automated test
10. Red blood cell sedimentation rate, to detect inflammation
11. Vaccine for influenza for administration into muscle, 0.5 ml dosage
12. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
13. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
14. Infusion of chemotherapy into a vein up to 1 hour
15. Infusion of chemotherapy into a vein
16. New patient office or other outpatient visit, typically 45 minutes
17. Established patient office or other outpatient visit, typically 5 minutes
18. Established patient office or other outpatient visit, typically 15 minutes
19. Established patient office or other outpatient, visit typically 25 minutes
20. Physician telephone patient service, 21-30 minutes of medical discussion

They took part in the Medicare Physician Quality Reporting System (PQRS).

They took part in the Million Hearts Initiative, which was deigned to improve cardiac outcomes.